Combining antibiotics to tackle antimicrobial resistance
- 26 March 2025
- journal article
- editorial
- Published by Springer Nature in Nature Microbiology
- Vol. 10 (4) , 813-816
Abstract
No abstract availableKeywords
Funding Information
- Wellcome Trust (226691/Z/22/Z, 226691/Z/22/Z, 226691/Z/22/Z)
- Research Councils UK (107136 36348, MR/Z505018/1)
- DH | National Institute for Health Research (CL-2022-07-001)
This publication has 13 references indexed in Scilit:
- Antimicrobial treatment imprecision: an outcome-based model to close the data-to-action loopThe Lancet Infectious Diseases, 2023
- Antimicrobial resistance and the Iraq wars: armed conflict as an underinvestigated pathway with growing significanceBMJ Global Health, 2023
- Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2021
- Personalised randomised controlled trial designs—a new paradigm to define optimal treatments for carbapenem-resistant infectionsThe Lancet Infectious Diseases, 2021
- Travel-Related Antimicrobial Resistance: A Systematic ReviewTropical Medicine and Infectious Disease, 2021
- Antimicrobial resistance among migrants in Europe: a systematic review and meta-analysisThe Lancet Infectious Diseases, 2018
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trialThe Lancet Infectious Diseases, 2018
- Chemical, microbial and antibiotic susceptibility analyses of groundwater after a major flood event in ChennaiScientific Data, 2017
- Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and ApplicationmBio, 2017
- Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 2015